DDrare: Database of Drug Development for Rare Diseases

Target Gene/Pathway（薬物標的遺伝子／パスウェイリスト）💬 Info on mouse-over

A B C D E F G H I J K L M N O PQR S T U V WXYZother

142 / 286 pathways

No.	KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related	KEGG GENES	KEGG DRUG	DrugBank	指定難病告示番号
1	Adipocytokine signaling pathway 💬	1件: JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
2	Adipocytokine signaling pathway 💬	1件: JAK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
3	Adipocytokine signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
4	Adipocytokine signaling pathway 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
5	Adipocytokine signaling pathway 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
6	Adrenergic signaling in cardiomyocytes 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
7	African trypanosomiasis 💬	4件: IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
8	African trypanosomiasis 💬	2件: IL12A, IL12B 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
9	African trypanosomiasis 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
10	African trypanosomiasis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
11	African trypanosomiasis 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
12	AGE-RAGE signaling pathway in diabetic complications 💬	5件: CCL2, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
13	AGE-RAGE signaling pathway in diabetic complications 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
14	AGE-RAGE signaling pathway in diabetic complications 💬	1件: JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
15	AGE-RAGE signaling pathway in diabetic complications 💬	1件: JAK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
16	AGE-RAGE signaling pathway in diabetic complications 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
17	AGE-RAGE signaling pathway in diabetic complications 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
18	Aldosterone synthesis and secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
19	Aldosterone synthesis and secretion 💬	1件: MC2R 💬	D00146 💬	Corticotropin	13件: 2 , 13, 14, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 💬
20	Allograft rejection 💬	2件: CD80, CD86 💬	D03203 💬	Abatacept	26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
21	Allograft rejection 💬	2件: IL10, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
22	Allograft rejection 💬	2件: IL12A, IL12B 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
23	Allograft rejection 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
24	Allograft rejection 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
25	Alzheimer disease 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
26	Alzheimer disease 💬	4件: IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
27	Alzheimer disease 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
28	Alzheimer disease 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
29	Alzheimer disease 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
30	Alzheimer disease 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
31	Alzheimer disease 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
32	Alzheimer disease 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
33	Amoebiasis 💬	4件: IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
34	Amoebiasis 💬	2件: IL12A, IL12B 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
35	Amoebiasis 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
36	Amoebiasis 💬	2件: IL1R1, IL1R2 💬	D02934 💬	Anakinra	19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
37	Amoebiasis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
38	Amoebiasis 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
39	Amphetamine addiction 💬	2件: CACNA1C, CACNA1D 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
40	Amphetamine addiction 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
41	Amphetamine addiction 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
42	Amphetamine addiction 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
43	Amyotrophic lateral sclerosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
44	Amyotrophic lateral sclerosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
45	Amyotrophic lateral sclerosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
46	Amyotrophic lateral sclerosis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
47	Amyotrophic lateral sclerosis 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
48	Amyotrophic lateral sclerosis 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
49	Antifolate resistance 💬	2件: DHFR, DHFR2 💬	D00142 💬	Methotrexate	35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
50	Antifolate resistance 💬	2件: DHFR, DHFR2 💬	D02115 💬	Methotrexate	35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
51	Antifolate resistance 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
52	Antifolate resistance 💬	3件: IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
53	Antifolate resistance 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
54	Antifolate resistance 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
55	Antigen processing and presentation 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
56	Antigen processing and presentation 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
57	Antigen processing and presentation 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
58	Apoptosis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
59	Apoptosis 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
60	Apoptosis 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
61	Arrhythmogenic right ventricular cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
62	Asthma 💬	2件: IL10, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
63	Asthma 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
64	Asthma 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
65	Autoimmune thyroid disease 💬	2件: CD80, CD86 💬	D03203 💬	Abatacept	26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
66	Autoimmune thyroid disease 💬	1件: IL10 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
67	Autoimmune thyroid disease 💬	1件: TPO 💬	D00401 💬	Methimazole	1件: 50 💬
68	Axon guidance 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
69	Axon guidance 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
70	Axon guidance 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
71	B cell receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
72	B cell receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
73	B cell receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
74	Biosynthesis of cofactors 💬	2件: DHFR, DHFR2 💬	D00142 💬	Methotrexate	35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
75	Biosynthesis of cofactors 💬	2件: DHFR, DHFR2 💬	D02115 💬	Methotrexate	35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
76	Breast cancer 💬	1件: TNFSF11 💬	D03684 💬	Denosumab	7件: 46, 50, 93, 95, 96, 274, 299 💬
77	C-type lectin receptor signaling pathway 💬	4件: IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
78	C-type lectin receptor signaling pathway 💬	3件: IL12A, IL12B, IL23A 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
79	C-type lectin receptor signaling pathway 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
80	C-type lectin receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
81	C-type lectin receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
82	C-type lectin receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
83	C-type lectin receptor signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
84	C-type lectin receptor signaling pathway 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
85	Calcium signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
86	Calcium signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
87	Calcium signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
88	Calcium signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
89	cAMP signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
90	cAMP signaling pathway 💬	1件: MC2R 💬	D00146 💬	Corticotropin	13件: 2 , 13, 14, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 💬
91	cAMP signaling pathway 💬	4件: PDE4A, PDE4B, PDE4C, PDE4D 💬	D08860 💬	Apremilast	6件: 46, 50, 56, 97, 162, 271 💬
92	Carbohydrate digestion and absorption 💬	1件: CACNA1D 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
93	Cardiac muscle contraction 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
94	Cell adhesion molecules 💬	2件: CD80, CD86 💬	D03203 💬	Abatacept	26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
95	Cell adhesion molecules 💬	1件: PDCD1 💬	D10316 💬	Nivolumab	12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
96	Cellular senescence 💬	1件: CACNA1D 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
97	Cellular senescence 💬	2件: IL1A, IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
98	Cellular senescence 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
99	Cellular senescence 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
100	Cellular senescence 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
101	cGMP-PKG signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
102	cGMP-PKG signaling pathway 💬	1件: PDE5A 💬	D02229 💬	Sildenafil	17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
103	cGMP-PKG signaling pathway 💬	1件: PDE5A 💬	D08514 💬	Sildenafil	17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
104	cGMP-PKG signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
105	cGMP-PKG signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
106	cGMP-PKG signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
107	Chagas disease 💬	5件: CCL2, IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
108	Chagas disease 💬	2件: IL12A, IL12B 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
109	Chagas disease 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
110	Chagas disease 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
111	Chagas disease 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
112	Chemokine signaling pathway 💬	1件: CCL2 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
113	Chemokine signaling pathway 💬	1件: JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
114	Chemokine signaling pathway 💬	2件: JAK2, JAK3 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
115	Cholinergic synapse 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
116	Cholinergic synapse 💬	1件: JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
117	Cholinergic synapse 💬	1件: JAK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
118	Circadian entrainment 💬	2件: CACNA1C, CACNA1D 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
119	Coronavirus disease - COVID-19 💬	4件: CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
120	Coronavirus disease - COVID-19 💬	2件: IL12A, IL12B 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
121	Coronavirus disease - COVID-19 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
122	Coronavirus disease - COVID-19 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
123	Coronavirus disease - COVID-19 💬	1件: JAK1 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
124	Coronavirus disease - COVID-19 💬	2件: JAK1, TYK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
125	Coronavirus disease - COVID-19 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
126	Coronavirus disease - COVID-19 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
127	Cortisol synthesis and secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
128	Cortisol synthesis and secretion 💬	1件: MC2R 💬	D00146 💬	Corticotropin	13件: 2 , 13, 14, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 💬
129	Cushing syndrome 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
130	Cushing syndrome 💬	1件: MC2R 💬	D00146 💬	Corticotropin	13件: 2 , 13, 14, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 💬
131	Cytokine-cytokine receptor interaction 💬	6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
132	Cytokine-cytokine receptor interaction 💬	3件: IL12A, IL12B, IL23A 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
133	Cytokine-cytokine receptor interaction 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
134	Cytokine-cytokine receptor interaction 💬	2件: IL1R1, IL1R2 💬	D02934 💬	Anakinra	19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
135	Cytokine-cytokine receptor interaction 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
136	Cytokine-cytokine receptor interaction 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
137	Cytokine-cytokine receptor interaction 💬	2件: LTA, TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
138	Cytokine-cytokine receptor interaction 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
139	Cytokine-cytokine receptor interaction 💬	1件: TNFSF11 💬	D03684 💬	Denosumab	7件: 46, 50, 93, 95, 96, 274, 299 💬
140	Cytosolic DNA-sensing pathway 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
141	Cytosolic DNA-sensing pathway 💬	2件: IL1B, IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
142	Dilated cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
143	Dilated cardiomyopathy 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
144	Dilated cardiomyopathy 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
145	Dilated cardiomyopathy 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
146	Dopaminergic synapse 💬	2件: CACNA1C, CACNA1D 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
147	Dopaminergic synapse 💬	3件: PPP3CA, PPP3CB, PPP3CC 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
148	Dopaminergic synapse 💬	3件: PPP3CA, PPP3CB, PPP3CC 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
149	Dopaminergic synapse 💬	3件: PPP3CA, PPP3CB, PPP3CC 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
150	EGFR tyrosine kinase inhibitor resistance 💬	1件: IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
151	EGFR tyrosine kinase inhibitor resistance 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
152	EGFR tyrosine kinase inhibitor resistance 💬	2件: JAK1, JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
153	EGFR tyrosine kinase inhibitor resistance 💬	2件: JAK1, JAK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
154	Endocrine and other factor-regulated calcium reabsorption 💬	1件: VDR 💬	D01518 💬	Alfacalcidol	6件: 41, 46, 49, 50, 96, 235 💬
155	Endocytosis 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
156	Epstein-Barr virus infection 💬	2件: IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
157	Epstein-Barr virus infection 💬	1件: JAK1 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
158	Epstein-Barr virus infection 💬	3件: JAK1, JAK3, TYK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
159	Epstein-Barr virus infection 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
160	Epstein-Barr virus infection 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
161	Fc epsilon RI signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
162	Fc epsilon RI signaling pathway 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
163	Fc epsilon RI signaling pathway 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
164	Fluid shear stress and atherosclerosis 💬	4件: CCL2, IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
165	Fluid shear stress and atherosclerosis 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
166	Fluid shear stress and atherosclerosis 💬	2件: IL1R1, IL1R2 💬	D02934 💬	Anakinra	19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
167	Fluid shear stress and atherosclerosis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
168	Fluid shear stress and atherosclerosis 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
169	Folate biosynthesis 💬	2件: DHFR, DHFR2 💬	D00142 💬	Methotrexate	35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
170	Folate biosynthesis 💬	2件: DHFR, DHFR2 💬	D02115 💬	Methotrexate	35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
171	FoxO signaling pathway 💬	2件: IL10, IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
172	FoxO signaling pathway 💬	1件: S1PR1 💬	D11460 💬	Siponimod	2件: 13, 50 💬
173	GABAergic synapse 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
174	Glucagon signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
175	Glucagon signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
176	Glucagon signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
177	Glutamatergic synapse 💬	2件: CACNA1C, CACNA1D 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
178	Glutamatergic synapse 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
179	Glutamatergic synapse 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
180	Glutamatergic synapse 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
181	GnRH secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
182	GnRH signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
183	Graft-versus-host disease 💬	2件: CD80, CD86 💬	D03203 💬	Abatacept	26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
184	Graft-versus-host disease 💬	4件: IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
185	Graft-versus-host disease 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
186	Graft-versus-host disease 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
187	Graft-versus-host disease 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
188	Growth hormone synthesis, secretion and action 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
189	Growth hormone synthesis, secretion and action 💬	1件: JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
190	Growth hormone synthesis, secretion and action 💬	1件: JAK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
191	Hematopoietic cell lineage 💬	4件: IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
192	Hematopoietic cell lineage 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
193	Hematopoietic cell lineage 💬	2件: IL1R1, IL1R2 💬	D02934 💬	Anakinra	19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
194	Hematopoietic cell lineage 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
195	Hematopoietic cell lineage 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
196	Hematopoietic cell lineage 💬	1件: MS4A1 💬	D02994 💬	Rituximab	47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
197	Hematopoietic cell lineage 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
198	Hematopoietic cell lineage 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
199	Hepatitis B 💬	2件: IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
200	Hepatitis B 💬	2件: JAK1, JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
201	Hepatitis B 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
202	Hepatitis B 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
203	Hepatitis B 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
204	Hepatitis C 💬	1件: JAK1 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
205	Hepatitis C 💬	2件: JAK1, TYK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
206	Hepatitis C 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
207	Hepatitis C 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
208	Hepatitis C 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
209	Herpes simplex virus 1 infection 💬	4件: CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
210	Herpes simplex virus 1 infection 💬	2件: IL12A, IL12B 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
211	Herpes simplex virus 1 infection 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
212	Herpes simplex virus 1 infection 💬	2件: JAK1, JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
213	Herpes simplex virus 1 infection 💬	3件: JAK1, JAK2, TYK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
214	Herpes simplex virus 1 infection 💬	2件: LTA, TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
215	Herpes simplex virus 1 infection 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
216	HIF-1 signaling pathway 💬	1件: IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
217	HIF-1 signaling pathway 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
218	Human cytomegalovirus infection 💬	4件: CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
219	Human cytomegalovirus infection 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
220	Human cytomegalovirus infection 💬	1件: IL1R1 💬	D02934 💬	Anakinra	19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
221	Human cytomegalovirus infection 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
222	Human cytomegalovirus infection 💬	1件: JAK1 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
223	Human cytomegalovirus infection 💬	1件: JAK1 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
224	Human cytomegalovirus infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
225	Human cytomegalovirus infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
226	Human cytomegalovirus infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
227	Human cytomegalovirus infection 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
228	Human cytomegalovirus infection 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
229	Human immunodeficiency virus 1 infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
230	Human immunodeficiency virus 1 infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
231	Human immunodeficiency virus 1 infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
232	Human immunodeficiency virus 1 infection 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
233	Human immunodeficiency virus 1 infection 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
234	Human immunodeficiency virus 1 infection 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
235	Human papillomavirus infection 💬	1件: JAK1 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
236	Human papillomavirus infection 💬	2件: JAK1, TYK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
237	Human papillomavirus infection 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
238	Human papillomavirus infection 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
239	Human papillomavirus infection 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
240	Human T-cell leukemia virus 1 infection 💬	1件: FDPS 💬	D00939 💬	Alendronic acid	7件: 19, 41, 46, 50, 271, 274, 299 💬
241	Human T-cell leukemia virus 1 infection 💬	1件: FDPS 💬	D07119 💬	Alendronic acid	7件: 19, 41, 46, 50, 271, 274, 299 💬
242	Human T-cell leukemia virus 1 infection 💬	1件: FDPS 💬	D00942 💬	Risedronic acid	8件: 46, 50, 66, 93, 95, 96, 113, 274 💬
243	Human T-cell leukemia virus 1 infection 💬	1件: FDPS 💬	D03234 💬	Risedronic acid	8件: 46, 50, 66, 93, 95, 96, 113, 274 💬
244	Human T-cell leukemia virus 1 infection 💬	1件: FDPS 💬	D08484 💬	Risedronic acid	8件: 46, 50, 66, 93, 95, 96, 113, 274 💬
245	Human T-cell leukemia virus 1 infection 💬	2件: IL1R1, IL1R2 💬	D02934 💬	Anakinra	19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
246	Human T-cell leukemia virus 1 infection 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
247	Human T-cell leukemia virus 1 infection 💬	2件: IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
248	Human T-cell leukemia virus 1 infection 💬	1件: JAK1 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
249	Human T-cell leukemia virus 1 infection 💬	2件: JAK1, JAK3 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
250	Human T-cell leukemia virus 1 infection 💬	2件: LTA, TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
251	Human T-cell leukemia virus 1 infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
252	Human T-cell leukemia virus 1 infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
253	Human T-cell leukemia virus 1 infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
254	Human T-cell leukemia virus 1 infection 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
255	Hypertrophic cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
256	Hypertrophic cardiomyopathy 💬	2件: IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
257	Hypertrophic cardiomyopathy 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
258	Hypertrophic cardiomyopathy 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
259	IL-17 signaling pathway 💬	4件: CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
260	IL-17 signaling pathway 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
261	IL-17 signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
262	IL-17 signaling pathway 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
263	Inflammatory bowel disease 💬	5件: IL10, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
264	Inflammatory bowel disease 💬	3件: IL12A, IL12B, IL23A 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
265	Inflammatory bowel disease 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
266	Inflammatory bowel disease 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
267	Inflammatory bowel disease 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
268	Inflammatory mediator regulation of TRP channels 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
269	Inflammatory mediator regulation of TRP channels 💬	1件: IL1B 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
270	Inflammatory mediator regulation of TRP channels 💬	1件: IL1R1 💬	D02934 💬	Anakinra	19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
271	Influenza A 💬	5件: CCL2, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
272	Influenza A 💬	1件: FDPS 💬	D00939 💬	Alendronic acid	7件: 19, 41, 46, 50, 271, 274, 299 💬
273	Influenza A 💬	1件: FDPS 💬	D07119 💬	Alendronic acid	7件: 19, 41, 46, 50, 271, 274, 299 💬
274	Influenza A 💬	1件: FDPS 💬	D00942 💬	Risedronic acid	8件: 46, 50, 66, 93, 95, 96, 113, 274 💬
275	Influenza A 💬	1件: FDPS 💬	D03234 💬	Risedronic acid	8件: 46, 50, 66, 93, 95, 96, 113, 274 💬
276	Influenza A 💬	1件: FDPS 💬	D08484 💬	Risedronic acid	8件: 46, 50, 66, 93, 95, 96, 113, 274 💬
277	Influenza A 💬	2件: IL12A, IL12B 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
278	Influenza A 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
279	Influenza A 💬	2件: JAK1, JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
280	Influenza A 💬	3件: JAK1, JAK2, TYK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
281	Influenza A 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
282	Influenza A 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
283	Insulin resistance 💬	2件: IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
284	Insulin resistance 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
285	Insulin resistance 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
286	Insulin secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
287	Intestinal immune network for IgA production 💬	2件: CD80, CD86 💬	D03203 💬	Abatacept	26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
288	Intestinal immune network for IgA production 💬	2件: IL10, IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
289	JAK-STAT signaling pathway 💬	2件: IL10, IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
290	JAK-STAT signaling pathway 💬	3件: IL12A, IL12B, IL23A 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
291	JAK-STAT signaling pathway 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
292	JAK-STAT signaling pathway 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
293	JAK-STAT signaling pathway 💬	2件: JAK1, JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
294	JAK-STAT signaling pathway 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
295	Kaposi sarcoma-associated herpesvirus infection 💬	1件: CD86 💬	D03203 💬	Abatacept	26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
296	Kaposi sarcoma-associated herpesvirus infection 💬	1件: IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
297	Kaposi sarcoma-associated herpesvirus infection 💬	2件: JAK1, JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
298	Kaposi sarcoma-associated herpesvirus infection 💬	3件: JAK1, JAK2, TYK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
299	Kaposi sarcoma-associated herpesvirus infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
300	Kaposi sarcoma-associated herpesvirus infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
301	Kaposi sarcoma-associated herpesvirus infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
302	Legionellosis 💬	2件: IL12A, IL12B 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
303	Legionellosis 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
304	Legionellosis 💬	3件: IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
305	Legionellosis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
306	Legionellosis 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
307	Leishmaniasis 💬	4件: IL10, IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
308	Leishmaniasis 💬	2件: IL12A, IL12B 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
309	Leishmaniasis 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
310	Leishmaniasis 💬	2件: JAK1, JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
311	Leishmaniasis 💬	2件: JAK1, JAK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
312	Leishmaniasis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
313	Leishmaniasis 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
314	Long-term potentiation 💬	1件: CACNA1C 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
315	Long-term potentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
316	Long-term potentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
317	Long-term potentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
318	Malaria 💬	5件: CCL2, IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
319	Malaria 💬	1件: IL12A 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
320	Malaria 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
321	Malaria 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
322	Malaria 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
323	MAPK signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
324	MAPK signaling pathway 💬	3件: IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
325	MAPK signaling pathway 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
326	MAPK signaling pathway 💬	1件: IL1R1 💬	D02934 💬	Anakinra	19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
327	MAPK signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
328	MAPK signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
329	MAPK signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
330	MAPK signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
331	MAPK signaling pathway 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
332	Measles 💬	2件: IL12A, IL12B 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
333	Measles 💬	3件: IL1A, IL1B, IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
334	Measles 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
335	Measles 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
336	Measles 💬	1件: JAK1 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
337	Measles 💬	3件: JAK1, JAK3, TYK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
338	Metabolic pathways 💬	2件: DHFR, DHFR2 💬	D00142 💬	Methotrexate	35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
339	Metabolic pathways 💬	2件: DHFR, DHFR2 💬	D02115 💬	Methotrexate	35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
340	Metabolic pathways 💬	1件: FDPS 💬	D00939 💬	Alendronic acid	7件: 19, 41, 46, 50, 271, 274, 299 💬
341	Metabolic pathways 💬	1件: FDPS 💬	D07119 💬	Alendronic acid	7件: 19, 41, 46, 50, 271, 274, 299 💬
342	Metabolic pathways 💬	1件: FDPS 💬	D00942 💬	Risedronic acid	8件: 46, 50, 66, 93, 95, 96, 113, 274 💬
343	Metabolic pathways 💬	1件: FDPS 💬	D03234 💬	Risedronic acid	8件: 46, 50, 66, 93, 95, 96, 113, 274 💬
344	Metabolic pathways 💬	1件: FDPS 💬	D08484 💬	Risedronic acid	8件: 46, 50, 66, 93, 95, 96, 113, 274 💬
345	Metabolic pathways 💬	4件: PDE4A, PDE4B, PDE4C, PDE4D 💬	D08860 💬	Apremilast	6件: 46, 50, 56, 97, 162, 271 💬
346	Metabolic pathways 💬	1件: PDE5A 💬	D02229 💬	Sildenafil	17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
347	Metabolic pathways 💬	1件: PDE5A 💬	D08514 💬	Sildenafil	17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
348	Metabolic pathways 💬	1件: TPO 💬	D00401 💬	Methimazole	1件: 50 💬
349	Mineral absorption 💬	1件: VDR 💬	D01518 💬	Alfacalcidol	6件: 41, 46, 49, 50, 96, 235 💬
350	Morphine addiction 💬	4件: PDE4A, PDE4B, PDE4C, PDE4D 💬	D08860 💬	Apremilast	6件: 46, 50, 56, 97, 162, 271 💬
351	mTOR signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
352	mTOR signaling pathway 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
353	mTOR signaling pathway 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
354	Natural killer cell mediated cytotoxicity 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
355	Natural killer cell mediated cytotoxicity 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
356	Natural killer cell mediated cytotoxicity 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
357	Natural killer cell mediated cytotoxicity 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
358	Natural killer cell mediated cytotoxicity 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
359	Natural killer cell mediated cytotoxicity 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
360	Necroptosis 💬	3件: IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
361	Necroptosis 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
362	Necroptosis 💬	2件: JAK1, JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
363	Necroptosis 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
364	Necroptosis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
365	Necroptosis 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
366	Neuroactive ligand-receptor interaction 💬	1件: CNR2 💬	D11312 💬	Ajulemic acid	3件: 50, 51, 299 💬
367	Neuroactive ligand-receptor interaction 💬	1件: MC2R 💬	D00146 💬	Corticotropin	13件: 2 , 13, 14, 46, 49, 50, 66, 75, 78, 84, 145, 193, 222 💬
368	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00407 💬	Methylprednisolone	44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
369	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00751 💬	Methylprednisolone	44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
370	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00979 💬	Methylprednisolone	44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
371	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D05000 💬	Methylprednisolone	44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
372	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D05001 💬	Methylprednisolone	44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
373	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D05002 💬	Methylprednisolone	44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
374	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D05000 💬	Methylprednisolone hemisuccinate	7件: 13, 49, 50, 51, 53, 97, 211 💬
375	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00472 💬	Prednisolone	40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
376	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00980 💬	Prednisolone	40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
377	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00981 💬	Prednisolone	40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
378	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00982 💬	Prednisolone	40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
379	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D01239 💬	Prednisolone	40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
380	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D01998 💬	Prednisolone	40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
381	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D02156 💬	Prednisolone	40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
382	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D03301 💬	Prednisolone	40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬
383	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00473 💬	Prednisone	47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬
384	Neuroactive ligand-receptor interaction 💬	2件: S1PR1, S1PR5 💬	D11460 💬	Siponimod	2件: 13, 50 💬
385	NF-kappa B signaling pathway 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
386	NF-kappa B signaling pathway 💬	2件: IL1B, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
387	NF-kappa B signaling pathway 💬	1件: IL1R1 💬	D02934 💬	Anakinra	19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
388	NF-kappa B signaling pathway 💬	2件: LTA, TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
389	NF-kappa B signaling pathway 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
390	NF-kappa B signaling pathway 💬	1件: TNFSF11 💬	D03684 💬	Denosumab	7件: 46, 50, 93, 95, 96, 274, 299 💬
391	NOD-like receptor signaling pathway 💬	4件: CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
392	NOD-like receptor signaling pathway 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
393	NOD-like receptor signaling pathway 💬	1件: JAK1 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
394	NOD-like receptor signaling pathway 💬	2件: JAK1, TYK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
395	NOD-like receptor signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
396	NOD-like receptor signaling pathway 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
397	Non-alcoholic fatty liver disease 💬	4件: IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
398	Non-alcoholic fatty liver disease 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
399	Non-alcoholic fatty liver disease 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
400	Non-alcoholic fatty liver disease 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
401	Non-alcoholic fatty liver disease 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
402	Non-small cell lung cancer 💬	1件: JAK3 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
403	One carbon pool by folate 💬	2件: DHFR, DHFR2 💬	D00142 💬	Methotrexate	35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
404	One carbon pool by folate 💬	2件: DHFR, DHFR2 💬	D02115 💬	Methotrexate	35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
405	Oocyte meiosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
406	Oocyte meiosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
407	Oocyte meiosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
408	Osteoclast differentiation 💬	3件: IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
409	Osteoclast differentiation 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
410	Osteoclast differentiation 💬	1件: IL1R1 💬	D02934 💬	Anakinra	19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
411	Osteoclast differentiation 💬	1件: JAK1 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
412	Osteoclast differentiation 💬	2件: JAK1, TYK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
413	Osteoclast differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
414	Osteoclast differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
415	Osteoclast differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
416	Osteoclast differentiation 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
417	Osteoclast differentiation 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
418	Osteoclast differentiation 💬	1件: TNFSF11 💬	D03684 💬	Denosumab	7件: 46, 50, 93, 95, 96, 274, 299 💬
419	Oxytocin signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
420	Oxytocin signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
421	Oxytocin signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
422	Oxytocin signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
423	Pancreatic cancer 💬	1件: JAK1 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
424	Pancreatic cancer 💬	1件: JAK1 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
425	Parathyroid hormone synthesis, secretion and action 💬	4件: PDE4A, PDE4B, PDE4C, PDE4D 💬	D08860 💬	Apremilast	6件: 46, 50, 56, 97, 162, 271 💬
426	Parathyroid hormone synthesis, secretion and action 💬	1件: TNFSF11 💬	D03684 💬	Denosumab	7件: 46, 50, 93, 95, 96, 274, 299 💬
427	Parathyroid hormone synthesis, secretion and action 💬	1件: VDR 💬	D01518 💬	Alfacalcidol	6件: 41, 46, 49, 50, 96, 235 💬
428	Pathogenic Escherichia coli infection 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
429	Pathogenic Escherichia coli infection 💬	3件: IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
430	Pathogenic Escherichia coli infection 💬	1件: IL1R1 💬	D02934 💬	Anakinra	19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
431	Pathogenic Escherichia coli infection 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
432	Pathogenic Escherichia coli infection 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
433	Pathways in cancer 💬	3件: IL12A, IL12B, IL23A 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
434	Pathways in cancer 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
435	Pathways in cancer 💬	1件: IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
436	Pathways in cancer 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
437	Pathways in cancer 💬	2件: JAK1, JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
438	Pathways in cancer 💬	3件: JAK1, JAK2, JAK3 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
439	Pathways of neurodegeneration - multiple diseases 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
440	Pathways of neurodegeneration - multiple diseases 💬	4件: IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
441	Pathways of neurodegeneration - multiple diseases 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
442	Pathways of neurodegeneration - multiple diseases 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
443	Pathways of neurodegeneration - multiple diseases 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
444	Pathways of neurodegeneration - multiple diseases 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
445	Pathways of neurodegeneration - multiple diseases 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
446	Pathways of neurodegeneration - multiple diseases 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
447	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	2件: JAK1, JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
448	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	2件: JAK1, JAK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
449	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	1件: PDCD1 💬	D10316 💬	Nivolumab	12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
450	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
451	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
452	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
453	Pertussis 💬	5件: IL10, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
454	Pertussis 💬	3件: IL12A, IL12B, IL23A 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
455	Pertussis 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
456	Pertussis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
457	Pertussis 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
458	PI3K-Akt signaling pathway 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
459	PI3K-Akt signaling pathway 💬	1件: IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
460	PI3K-Akt signaling pathway 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
461	PI3K-Akt signaling pathway 💬	2件: JAK1, JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
462	PI3K-Akt signaling pathway 💬	3件: JAK1, JAK2, JAK3 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
463	Primary immunodeficiency 💬	1件: JAK3 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
464	Prion disease 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
465	Prion disease 💬	4件: IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
466	Prion disease 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
467	Prion disease 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
468	Prion disease 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
469	Prion disease 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
470	Prion disease 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
471	Prion disease 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
472	Prolactin signaling pathway 💬	1件: JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
473	Prolactin signaling pathway 💬	1件: JAK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
474	Prolactin signaling pathway 💬	1件: TNFSF11 💬	D03684 💬	Denosumab	7件: 46, 50, 93, 95, 96, 274, 299 💬
475	Prostate cancer 💬	1件: IL1R2 💬	D02934 💬	Anakinra	19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
476	Proteoglycans in cancer 💬	1件: IL12B 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
477	Proteoglycans in cancer 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
478	Proteoglycans in cancer 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
479	Proteoglycans in cancer 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
480	Purine metabolism 💬	4件: PDE4A, PDE4B, PDE4C, PDE4D 💬	D08860 💬	Apremilast	6件: 46, 50, 56, 97, 162, 271 💬
481	Purine metabolism 💬	1件: PDE5A 💬	D02229 💬	Sildenafil	17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
482	Purine metabolism 💬	1件: PDE5A 💬	D08514 💬	Sildenafil	17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
483	Renin secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
484	Renin secretion 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
485	Renin secretion 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
486	Renin secretion 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
487	Retrograde endocannabinoid signaling 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
488	Rheumatoid arthritis 💬	5件: CCL2, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
489	Rheumatoid arthritis 💬	2件: CD80, CD86 💬	D03203 💬	Abatacept	26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
490	Rheumatoid arthritis 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
491	Rheumatoid arthritis 💬	1件: IL23A 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
492	Rheumatoid arthritis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
493	Rheumatoid arthritis 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
494	Rheumatoid arthritis 💬	1件: TNFSF11 💬	D03684 💬	Denosumab	7件: 46, 50, 93, 95, 96, 274, 299 💬
495	RIG-I-like receptor signaling pathway 💬	2件: IL12A, IL12B 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
496	RIG-I-like receptor signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
497	RIG-I-like receptor signaling pathway 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
498	RIG-I-like receptor signaling pathway 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
499	Salmonella infection 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
500	Salmonella infection 💬	3件: IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
501	Salmonella infection 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
502	Salmonella infection 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
503	Serotonergic synapse 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
504	Shigellosis 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
505	Shigellosis 💬	2件: IL1B, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
506	Shigellosis 💬	1件: IL1R1 💬	D02934 💬	Anakinra	19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
507	Shigellosis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
508	Shigellosis 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
509	Signaling pathways regulating pluripotency of stem cells 💬	2件: JAK1, JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
510	Signaling pathways regulating pluripotency of stem cells 💬	3件: JAK1, JAK2, JAK3 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
511	Sphingolipid signaling pathway 💬	2件: S1PR1, S1PR5 💬	D11460 💬	Siponimod	2件: 13, 50 💬
512	Sphingolipid signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
513	Sphingolipid signaling pathway 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
514	Sphingolipid signaling pathway 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
515	Staphylococcus aureus infection 💬	1件: IL10 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
516	Systemic lupus erythematosus 💬	2件: CD80, CD86 💬	D03203 💬	Abatacept	26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
517	Systemic lupus erythematosus 💬	2件: IL10, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
518	Systemic lupus erythematosus 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
519	Systemic lupus erythematosus 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
520	T cell receptor signaling pathway 💬	2件: IL10, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
521	T cell receptor signaling pathway 💬	1件: PDCD1 💬	D10316 💬	Nivolumab	12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
522	T cell receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
523	T cell receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
524	T cell receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
525	T cell receptor signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
526	T cell receptor signaling pathway 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
527	Taste transduction 💬	1件: CACNA1C 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
528	Terpenoid backbone biosynthesis 💬	1件: FDPS 💬	D00939 💬	Alendronic acid	7件: 19, 41, 46, 50, 271, 274, 299 💬
529	Terpenoid backbone biosynthesis 💬	1件: FDPS 💬	D07119 💬	Alendronic acid	7件: 19, 41, 46, 50, 271, 274, 299 💬
530	Terpenoid backbone biosynthesis 💬	1件: FDPS 💬	D00942 💬	Risedronic acid	8件: 46, 50, 66, 93, 95, 96, 113, 274 💬
531	Terpenoid backbone biosynthesis 💬	1件: FDPS 💬	D03234 💬	Risedronic acid	8件: 46, 50, 66, 93, 95, 96, 113, 274 💬
532	Terpenoid backbone biosynthesis 💬	1件: FDPS 💬	D08484 💬	Risedronic acid	8件: 46, 50, 66, 93, 95, 96, 113, 274 💬
533	TGF-beta signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
534	TGF-beta signaling pathway 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
535	TGF-beta signaling pathway 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
536	Th1 and Th2 cell differentiation 💬	2件: IL12A, IL12B 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
537	Th1 and Th2 cell differentiation 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
538	Th1 and Th2 cell differentiation 💬	2件: JAK1, JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
539	Th1 and Th2 cell differentiation 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
540	Th1 and Th2 cell differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
541	Th1 and Th2 cell differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
542	Th1 and Th2 cell differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
543	Th17 cell differentiation 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
544	Th17 cell differentiation 💬	2件: IL1B, IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
545	Th17 cell differentiation 💬	1件: IL1R1 💬	D02934 💬	Anakinra	19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
546	Th17 cell differentiation 💬	1件: IL23A 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
547	Th17 cell differentiation 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
548	Th17 cell differentiation 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
549	Th17 cell differentiation 💬	2件: JAK1, JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
550	Th17 cell differentiation 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
551	Th17 cell differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
552	Th17 cell differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
553	Th17 cell differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
554	Thyroid hormone synthesis 💬	1件: TPO 💬	D00401 💬	Methimazole	1件: 50 💬
555	Tight junction 💬	1件: CACNA1D 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
556	TNF signaling pathway 💬	4件: CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
557	TNF signaling pathway 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
558	TNF signaling pathway 💬	2件: LTA, TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
559	TNF signaling pathway 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
560	Toll-like receptor signaling pathway 💬	2件: CD80, CD86 💬	D03203 💬	Abatacept	26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
561	Toll-like receptor signaling pathway 💬	2件: IL12A, IL12B 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
562	Toll-like receptor signaling pathway 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
563	Toll-like receptor signaling pathway 💬	3件: IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
564	Toll-like receptor signaling pathway 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
565	Toll-like receptor signaling pathway 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
566	Toxoplasmosis 💬	2件: IL10, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
567	Toxoplasmosis 💬	2件: IL12A, IL12B 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
568	Toxoplasmosis 💬	2件: JAK1, JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
569	Toxoplasmosis 💬	3件: JAK1, JAK2, TYK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
570	Toxoplasmosis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
571	Toxoplasmosis 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
572	Transcriptional misregulation in cancer 💬	1件: CD86 💬	D03203 💬	Abatacept	26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
573	Transcriptional misregulation in cancer 💬	1件: IL1R2 💬	D02934 💬	Anakinra	19件: 2 , 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 💬
574	Transcriptional misregulation in cancer 💬	1件: IL6 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
575	Tuberculosis 💬	5件: IL10, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
576	Tuberculosis 💬	3件: IL12A, IL12B, IL23A 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
577	Tuberculosis 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
578	Tuberculosis 💬	2件: JAK1, JAK2 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
579	Tuberculosis 💬	2件: JAK1, JAK2 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
580	Tuberculosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
581	Tuberculosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
582	Tuberculosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
583	Tuberculosis 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
584	Tuberculosis 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
585	Tuberculosis 💬	1件: VDR 💬	D01518 💬	Alfacalcidol	6件: 41, 46, 49, 50, 96, 235 💬
586	Type I diabetes mellitus 💬	2件: CD80, CD86 💬	D03203 💬	Abatacept	26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
587	Type I diabetes mellitus 💬	2件: IL12A, IL12B 💬	D09214 💬	Ustekinumab	15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
588	Type I diabetes mellitus 💬	3件: IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
589	Type I diabetes mellitus 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
590	Type I diabetes mellitus 💬	2件: LTA, TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
591	Type I diabetes mellitus 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
592	Type II diabetes mellitus 💬	2件: CACNA1C, CACNA1D 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
593	Type II diabetes mellitus 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
594	Type II diabetes mellitus 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
595	Type II diabetes mellitus 💬	1件: TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
596	Tyrosine metabolism 💬	1件: TPO 💬	D00401 💬	Methimazole	1件: 50 💬
597	Vascular smooth muscle contraction 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D00437 💬	Nifedipine	2件: 50, 81 💬
598	VEGF signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
599	VEGF signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
600	VEGF signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
601	Viral carcinogenesis 💬	1件: JAK1 💬	D10308 💬	Baricitinib	9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
602	Viral carcinogenesis 💬	2件: JAK1, JAK3 💬	D09970 💬	Tofacitinib	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
603	Viral myocarditis 💬	2件: CD80, CD86 💬	D03203 💬	Abatacept	26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
604	Viral protein interaction with cytokine and cytokine receptor 💬	4件: CCL2, IL10, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
605	Viral protein interaction with cytokine and cytokine receptor 💬	1件: IL2RA 💬	D03058 💬	Basiliximab	7件: 2 , 50, 65, 66, 97, 222, 228 💬
606	Viral protein interaction with cytokine and cytokine receptor 💬	1件: IL6R 💬	D02596 💬	Tocilizumab	18件: 2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
607	Viral protein interaction with cytokine and cytokine receptor 💬	2件: LTA, TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
608	Viral protein interaction with cytokine and cytokine receptor 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬
609	Wnt signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
610	Wnt signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00107 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
611	Wnt signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D08556 💬	Tacrolimus	32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
612	Yersinia infection 💬	5件: CCL2, IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
613	Yersinia infection 💬	1件: IL1B 💬	D09911 💬	Gevokizumab	4件: 41, 50, 56, 269 💬
614	Yersinia infection 💬	1件: TNF 💬	D00742 💬	Etanercept	15件: 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
615	Yersinia infection 💬	1件: TNF 💬	D02598 💬	Infliximab	25件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 162, 164, 269, 271 💬

先頭へ